MDGL Latest Press Releases

-- October 20, 2026 --

Madrigal Pharmaceuticals to Release Third-Quarter 2026 Financial Results and Host Webcast on November 3, 2026 Globe Newswire 8:00 AM

-- October 15, 2026 --

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- October 6, 2026 --

Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk Variants Globe Newswire 8:00 AM

-- September 16, 2026 --

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- September 2, 2026 --

Madrigal Pharmaceuticals to Participate in the 2026 Cantor Global Healthcare Conference Globe Newswire 8:00 AM

-- August 20, 2026 --

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- August 12, 2026 --

Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors Globe Newswire 8:00 AM

-- August 6, 2026 --

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference Globe Newswire 8:00 AM

-- July 30, 2026 --

Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates Globe Newswire 7:00 AM

-- July 21, 2026 --

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- July 16, 2026 --

Madrigal Pharmaceuticals to Release Second-Quarter 2026 Financial Results and Host Webcast on July 30, 2026 Globe Newswire 8:00 AM

-- July 13, 2026 --

Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio Globe Newswire 8:00 AM

-- July 6, 2026 --

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- July 1, 2026 --

Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH PRNewswire 9:20 PM

-- June 22, 2026 --

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- June 4, 2026 --

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- June 3, 2026 --

Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026 Globe Newswire 8:00 AM

-- May 27, 2026 --

Madrigal Presents Data Demonstrating Rezdiffra Reduced Markers of Cardiovascular and Liver-Related Risk in Patients with MASH Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes